Clinical Trial Update: Long-Term Follow-up Study for Patients From AVXS-101-CL-101

View source ↗

Summary

This clinical-trial update reports on the long-term follow-up study for spinal muscular atrophy patients treated with AVXS-101 (Zolgensma) and notes the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Zolgensma (onasemnogene abeparvovec)

Snippet

Sponsor: Novartis Gene Therapies | Conditions: Spinal Muscular Atrophy 1 | Status: ACTIVE_NOT_RECRUITING